448 related articles for article (PubMed ID: 30149598)
1. Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus.
Saiz JC; Oya NJ; Blázquez AB; Escribano-Romero E; Martín-Acebes MA
Viruses; 2018 Aug; 10(9):. PubMed ID: 30149598
[TBL] [Abstract][Full Text] [Related]
2. The Race To Find Antivirals for Zika Virus.
Saiz JC; Martín-Acebes MA
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348160
[TBL] [Abstract][Full Text] [Related]
3. Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update.
Han Y; Mesplède T
Expert Opin Investig Drugs; 2018 Dec; 27(12):951-962. PubMed ID: 30430882
[TBL] [Abstract][Full Text] [Related]
4. Current Breakthroughs in Structure-based Design of Synthetic and Natural Sourced Inhibitors Against Zika Viral Targets.
Nandi S; Kaur R; Kumar M; Sharma A; Naaz A; Mandal SC
Curr Top Med Chem; 2018; 18(20):1792-1803. PubMed ID: 30465510
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antiviral activity of Sofosbuvir and type-I interferons (α and β) against Zika virus.
Snyder B; Goebel S; Koide F; Ptak R; Kalkeri R
J Med Virol; 2018 Jan; 90(1):8-12. PubMed ID: 28851097
[TBL] [Abstract][Full Text] [Related]
6. A sensitive virus yield assay for evaluation of Antivirals against Zika Virus.
Goebel S; Snyder B; Sellati T; Saeed M; Ptak R; Murray M; Bostwick R; Rayner J; Koide F; Kalkeri R
J Virol Methods; 2016 Dec; 238():13-20. PubMed ID: 27678028
[TBL] [Abstract][Full Text] [Related]
7. Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics.
McArthur MA
Viruses; 2017 Jun; 9(6):. PubMed ID: 28608813
[TBL] [Abstract][Full Text] [Related]
8. Drug Repurposing: New Treatments for Zika Virus Infection?
Cheng F; Murray JL; Rubin DH
Trends Mol Med; 2016 Nov; 22(11):919-921. PubMed ID: 27692879
[TBL] [Abstract][Full Text] [Related]
9. Natural products as Zika antivirals.
Fong YD; Chu JJH
Med Res Rev; 2022 Sep; 42(5):1739-1780. PubMed ID: 35593443
[TBL] [Abstract][Full Text] [Related]
10. Repurposing drugs for use against Zika virus infection.
Devillers J
SAR QSAR Environ Res; 2018 Feb; 29(2):103-115. PubMed ID: 29299939
[TBL] [Abstract][Full Text] [Related]
11. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel small-molecule inhibitors of Zika virus infection.
Micewicz ED; Khachatoorian R; French SW; Ruchala P
Bioorg Med Chem Lett; 2018 Feb; 28(3):452-458. PubMed ID: 29258771
[TBL] [Abstract][Full Text] [Related]
13. Identification of Inhibitors of ZIKV Replication.
Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
Loe MWC; Lee RCH; Chu JJH
Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333
[TBL] [Abstract][Full Text] [Related]
15. Strategies for Zika drug discovery.
Zou J; Shi PY
Curr Opin Virol; 2019 Apr; 35():19-26. PubMed ID: 30852345
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection.
Zou M; Liu H; Li J; Yao X; Chen Y; Ke C; Liu S
Biochem Pharmacol; 2020 Jul; 177():113962. PubMed ID: 32272109
[TBL] [Abstract][Full Text] [Related]
17. Zika virus: from an obscurity to a priority.
Lee CY; Ng LFP
Microbes Infect; 2018 Dec; 20(11-12):635-645. PubMed ID: 29530643
[TBL] [Abstract][Full Text] [Related]
18. Zika Virus: Emergence, Phylogenetics, Challenges, and Opportunities.
Rajah MM; Pardy RD; Condotta SA; Richer MJ; Sagan SM
ACS Infect Dis; 2016 Nov; 2(11):763-772. PubMed ID: 27704772
[TBL] [Abstract][Full Text] [Related]
19. Nuclear import inhibitor N-(4-hydroxyphenyl) retinamide targets Zika virus (ZIKV) nonstructural protein 5 to inhibit ZIKV infection.
Wang C; Yang SNY; Smith K; Forwood JK; Jans DA
Biochem Biophys Res Commun; 2017 Dec; 493(4):1555-1559. PubMed ID: 28988109
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus.
Pitts JD; Li PC; de Wispelaere M; Yang PL
Antiviral Res; 2017 Nov; 147():124-130. PubMed ID: 29051080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
